ABT logo

Abbott Laboratories (ABT) Cash from investing

annual CFI:

-$2.34B+$795.00M(+25.38%)
December 31, 2024

Summary

  • As of today (August 21, 2025), ABT annual cash flow from investing activities is -$2.34 billion, with the most recent change of +$795.00 million (+25.38%) on December 31, 2024.
  • During the last 3 years, ABT annual CFI has fallen by -$330.00 million (-16.43%).
  • ABT annual CFI is now -675.86% below its all-time high of $406.00 million, reached on December 31, 2015.

Performance

ABT Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

quarterly CFI:

-$582.00M-$112.00M(-23.83%)
June 30, 2025

Summary

  • As of today (August 21, 2025), ABT quarterly cash flow from investing activities is -$582.00 million, with the most recent change of -$112.00 million (-23.83%) on June 30, 2025.
  • Over the past year, ABT quarterly CFI has dropped by -$129.00 million (-28.48%).
  • ABT quarterly CFI is now -137.16% below its all-time high of $1.57 billion, reached on December 31, 2015.

Performance

ABT quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

TTM CFI:

-$2.51B-$129.00M(-5.41%)
June 30, 2025

Summary

  • As of today (August 21, 2025), ABT TTM cash flow from investing activities is -$2.51 billion, with the most recent change of -$129.00 million (-5.41%) on June 30, 2025.
  • Over the past year, ABT TTM CFI has dropped by -$176.00 million (-7.53%).
  • ABT TTM CFI is now -400.12% below its all-time high of $837.00 million, reached on March 31, 2016.

Performance

ABT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ABT Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.4%-28.5%-7.5%
3 y3 years-16.4%-120.5%-29.1%
5 y5 years-28.8%+6.0%-29.9%

ABT Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-34.4%+25.4%-120.5%+52.0%-44.4%+19.8%
5 y5-year-34.4%+25.4%-120.5%+52.0%-44.4%+19.8%
alltimeall time-675.9%+80.8%-137.2%+92.4%-400.1%+79.4%

ABT Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$582.00M(+23.8%)
-$2.51B(+5.4%)
Mar 2025
-
-$470.00M(-45.7%)
-$2.38B(+1.9%)
Dec 2024
-$2.34B(-25.4%)
-$866.00M(+45.8%)
-$2.34B(+1.8%)
Sep 2024
-
-$594.00M(+31.1%)
-$2.30B(-1.7%)
Jun 2024
-
-$453.00M(+6.6%)
-$2.34B(-24.5%)
Mar 2024
-
-$425.00M(-48.4%)
-$3.10B(-1.2%)
Dec 2023
-$3.13B(+80.1%)
-$824.00M(+30.0%)
-$3.13B(+6.5%)
Sep 2023
-
-$634.00M(-47.7%)
-$2.94B(+5.4%)
Jun 2023
-
-$1.21B(+162.6%)
-$2.79B(+51.5%)
Mar 2023
-
-$462.00M(-26.9%)
-$1.84B(+5.9%)
Dec 2022
-$1.74B(-13.3%)
-$632.00M(+30.6%)
-$1.74B(-2.2%)
Sep 2022
-
-$484.00M(+83.3%)
-$1.78B(-8.6%)
Jun 2022
-
-$264.00M(-26.7%)
-$1.95B(0.0%)
Mar 2022
-
-$360.00M(-46.3%)
-$1.95B(-3.1%)
Dec 2021
-$2.01B(-9.3%)
-$671.00M(+3.1%)
-$2.01B(-2.9%)
Sep 2021
-
-$651.00M(+146.6%)
-$2.07B(+9.5%)
Jun 2021
-
-$264.00M(-37.4%)
-$1.89B(-15.8%)
Mar 2021
-
-$422.00M(-42.3%)
-$2.24B(+1.3%)
Dec 2020
-$2.21B(+22.0%)
-$731.00M(+54.9%)
-$2.21B(+12.3%)
Sep 2020
-
-$472.00M(-23.7%)
-$1.97B(+2.1%)
Jun 2020
-
-$619.00M(+57.5%)
-$1.93B(+6.7%)
Mar 2020
-
-$393.00M(-19.6%)
-$1.81B(-0.2%)
Dec 2019
-$1.81B(+33.8%)
-$489.00M(+13.2%)
-$1.81B(-0.4%)
Sep 2019
-
-$432.00M(-13.3%)
-$1.82B(+6.4%)
Jun 2019
-
-$498.00M(+25.8%)
-$1.71B(+13.1%)
Mar 2019
-
-$396.00M(-20.2%)
-$1.51B(+11.7%)
Dec 2018
-$1.36B(-85.9%)
-$496.00M(+53.6%)
-$1.36B(-66.2%)
Sep 2018
-
-$323.00M(+8.0%)
-$4.01B(+0.4%)
Jun 2018
-
-$299.00M(+25.6%)
-$4.00B(+7.9%)
Mar 2018
-
-$238.00M(-92.4%)
-$3.70B(-61.5%)
Dec 2017
-$9.62B(+3778.2%)
-$3.15B(+930.1%)
-$9.62B(+95.6%)
Sep 2017
-
-$306.00M(+5000.0%)
-$4.92B(-4.8%)
Jun 2017
-
-$6.00M(-99.9%)
-$5.16B(-22.1%)
Mar 2017
-
-$6.15B(-497.0%)
-$6.63B(+2572.6%)
Dec 2016
-$248.00M(-161.1%)
$1.55B(-379.8%)
-$248.00M(+6.9%)
Sep 2016
-
-$554.00M(-62.3%)
-$232.00M(-73.5%)
Jun 2016
-
-$1.47B(-750.4%)
-$875.00M(-204.5%)
Mar 2016
-
$226.00M(-85.6%)
$837.00M(+106.2%)
Dec 2015
$406.00M(-301.0%)
$1.57B(-230.8%)
$406.00M(-134.7%)
Sep 2015
-
-$1.20B(-594.6%)
-$1.17B(+46.6%)
Jun 2015
-
$242.00M(-218.0%)
-$798.00M(-524.5%)
Mar 2015
-
-$205.00M(+1950.0%)
$188.00M(-193.1%)
Dec 2014
-$202.00M(-94.9%)
-$10.00M(-98.8%)
-$202.00M(-131.2%)
Sep 2014
-
-$825.00M(-167.2%)
$647.70M(-152.9%)
Jun 2014
-
$1.23B(-306.4%)
-$1.22B(-49.3%)
Mar 2014
-
-$595.00M(-170.9%)
-$2.42B(-38.5%)
Dec 2013
-$3.93B(-29.3%)
$839.70M(-131.1%)
-$3.93B(-28.2%)
Sep 2013
-
-$2.70B(-7575.7%)
-$5.47B(+65.5%)
Jun 2013
-
$36.07M(-101.7%)
-$3.31B(+24.6%)
Mar 2013
-
-$2.11B(+199.4%)
-$2.66B(-52.2%)
Dec 2012
-$5.56B(-2231.6%)
-$704.15M(+32.5%)
-$5.56B(+59.2%)
Sep 2012
-
-$531.61M(-177.2%)
-$3.49B(+77.4%)
Jun 2012
-
$688.37M(-113.7%)
-$1.97B(-19.7%)
Mar 2012
-
-$5.01B(-467.4%)
-$2.45B(-1039.5%)
Dec 2011
$260.83M(-102.1%)
$1.36B(+37.5%)
$260.83M(-107.4%)
Sep 2011
-
$992.00M(+382.5%)
-$3.54B(-48.9%)
Jun 2011
-
$205.59M(-108.9%)
-$6.93B(+1.4%)
Mar 2011
-
-$2.30B(-5.7%)
-$6.83B(-44.0%)
Dec 2010
-$12.19B(+229.5%)
-$2.44B(+2.0%)
-$12.19B(+48.9%)
Sep 2010
-
-$2.39B(-887.6%)
-$8.19B(+12.0%)
Jun 2010
-
$303.83M(-104.0%)
-$7.31B(-25.0%)
Mar 2010
-
-$7.66B(-590.0%)
-$9.75B(+163.7%)
Dec 2009
-$3.70B(+112.8%)
$1.56B(-202.9%)
-$3.70B(-29.7%)
Sep 2009
-
-$1.52B(-29.0%)
-$5.26B(+38.5%)
Jun 2009
-
-$2.14B(+33.1%)
-$3.80B(+55.1%)
Mar 2009
-
-$1.61B(>+9900.0%)
-$2.45B(+41.0%)
Dec 2008
-$1.74B(+52.9%)
-$2.61M(-95.2%)
-$1.74B(-11.5%)
Sep 2008
-
-$54.10M(-93.1%)
-$1.96B(-13.4%)
Jun 2008
-
-$788.04M(-11.8%)
-$2.27B(+29.5%)
Mar 2008
-
-$893.16M(+291.1%)
-$1.75B(+54.1%)
Dec 2007
-$1.14B(-90.0%)
-$228.36M(-36.3%)
-$1.14B(-76.5%)
Sep 2007
-
-$358.28M(+32.0%)
-$4.83B(-0.1%)
Jun 2007
-
-$271.32M(-2.5%)
-$4.83B(-57.6%)
Mar 2007
-
-$278.32M(-92.9%)
-$11.42B(+0.7%)
Dec 2006
-$11.33B
-$3.92B(+975.4%)
-$11.33B(+42.0%)
Sep 2006
-
-$364.58M(-94.7%)
-$7.98B(+1.9%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$6.85B(+3438.1%)
-$7.83B(+558.5%)
Mar 2006
-
-$193.65M(-66.0%)
-$1.19B(+100.5%)
Dec 2005
-$593.08M(-81.0%)
-$570.36M(+167.3%)
-$593.08M(-248.4%)
Sep 2005
-
-$213.35M(+0.9%)
$399.54M(+16.6%)
Jun 2005
-
-$211.51M(-152.6%)
$342.68M(-124.3%)
Mar 2005
-
$402.14M(-4.8%)
-$1.41B(-54.8%)
Dec 2004
-$3.12B(+91.4%)
$422.25M(-256.3%)
-$3.12B(-23.7%)
Sep 2004
-
-$270.20M(-86.2%)
-$4.09B(-4.7%)
Jun 2004
-
-$1.96B(+49.9%)
-$4.29B(+60.6%)
Mar 2004
-
-$1.31B(+139.5%)
-$2.67B(+63.9%)
Dec 2003
-$1.63B(-13.3%)
-$546.90M(+16.4%)
-$1.63B(+13.0%)
Sep 2003
-
-$469.93M(+36.1%)
-$1.44B(+9.7%)
Jun 2003
-
-$345.38M(+28.7%)
-$1.32B(-29.1%)
Mar 2003
-
-$268.39M(-25.3%)
-$1.85B(-1.5%)
Dec 2002
-$1.88B(-77.6%)
-$359.28M(+5.0%)
-$1.88B(-11.1%)
Sep 2002
-
-$342.14M(-61.3%)
-$2.12B(-10.5%)
Jun 2002
-
-$884.39M(+199.0%)
-$2.37B(-22.8%)
Mar 2002
-
-$295.81M(-50.3%)
-$3.06B(-63.5%)
Dec 2001
-$8.38B(+1257.5%)
-$595.38M(+0.7%)
-$8.38B(+4.4%)
Sep 2001
-
-$591.13M(-62.6%)
-$8.03B(+7.5%)
Jun 2001
-
-$1.58B(-71.8%)
-$7.47B(+21.8%)
Mar 2001
-
-$5.62B(+2238.5%)
-$6.13B(+892.9%)
Dec 2000
-$617.66M(-48.5%)
-$240.16M(+671.2%)
-$617.66M(-23.3%)
Sep 2000
-
-$31.14M(-87.3%)
-$805.79M(-31.4%)
Jun 2000
-
-$244.91M(+141.4%)
-$1.17B(+0.7%)
Mar 2000
-
-$101.45M(-76.3%)
-$1.17B(-2.7%)
Dec 1999
-$1.20B(-15.7%)
-$428.29M(+7.1%)
-$1.20B(+7.0%)
Sep 1999
-
-$399.99M(+69.1%)
-$1.12B(+21.9%)
Jun 1999
-
-$236.52M(+77.2%)
-$918.72M(-31.3%)
Mar 1999
-
-$133.46M(-61.8%)
-$1.34B(-5.9%)
Dec 1998
-$1.42B(+18.6%)
-$349.62M(+75.6%)
-$1.42B(+5.5%)
Sep 1998
-
-$199.13M(-69.6%)
-$1.35B(-8.0%)
Jun 1998
-
-$654.83M(+201.4%)
-$1.46B(+20.4%)
Mar 1998
-
-$217.28M(-21.2%)
-$1.22B(+1.5%)
Dec 1997
-$1.20B(-38.7%)
-$275.68M(-12.8%)
-$1.20B(-8.9%)
Sep 1997
-
-$316.01M(-22.4%)
-$1.31B(+4.6%)
Jun 1997
-
-$407.16M(+104.8%)
-$1.26B(-35.4%)
Mar 1997
-
-$198.82M(-49.3%)
-$1.94B(-0.5%)
Dec 1996
-$1.96B(+88.4%)
-$392.31M(+51.9%)
-$1.96B(+11.2%)
Sep 1996
-
-$258.31M(-76.4%)
-$1.76B(-0.3%)
Jun 1996
-
-$1.10B(+423.2%)
-$1.76B(+107.3%)
Mar 1996
-
-$209.34M(+7.2%)
-$850.93M(-18.0%)
Dec 1995
-$1.04B(+9.9%)
-$195.30M(-26.0%)
-$1.04B(+0.3%)
Sep 1995
-
-$263.78M(+44.5%)
-$1.03B(-2.5%)
Jun 1995
-
-$182.51M(-53.9%)
-$1.06B(-4.8%)
Mar 1995
-
-$396.13M(+105.8%)
-$1.11B(+18.1%)
Dec 1994
-$944.09M(+18.9%)
-$192.49M(-33.6%)
-$944.09M(+10.6%)
Sep 1994
-
-$290.07M(+22.8%)
-$853.34M(+11.8%)
Jun 1994
-
-$236.24M(+4.9%)
-$763.17M(-2.2%)
Mar 1994
-
-$225.29M(+121.4%)
-$780.13M(-1.7%)
Dec 1993
-$793.84M(+18.9%)
-$101.74M(-49.1%)
-$793.84M(-17.0%)
Sep 1993
-
-$199.90M(-21.1%)
-$956.20M(-4.4%)
Jun 1993
-
-$253.20M(+5.9%)
-$999.80M(+50.4%)
Mar 1993
-
-$239.00M(-9.5%)
-$664.70M(-0.4%)
Dec 1992
-$667.58M(+4.0%)
-$264.10M(+8.5%)
-$667.60M(+2.2%)
Sep 1992
-
-$243.50M(-397.3%)
-$653.40M(+11.5%)
Jun 1992
-
$81.90M(-133.9%)
-$586.10M(-33.8%)
Mar 1992
-
-$241.90M(-3.2%)
-$885.90M(+38.0%)
Dec 1991
-$642.11M(+3.9%)
-$249.90M(+41.8%)
-$642.10M(+56.5%)
Sep 1991
-
-$176.20M(-19.1%)
-$410.30M(+2.9%)
Jun 1991
-
-$217.90M(<-9900.0%)
-$398.70M(-7.4%)
Mar 1991
-
$1.90M(-110.5%)
-$430.60M(-30.4%)
Dec 1990
-$618.27M(-39.5%)
-$18.10M(-89.0%)
-$618.30M(+3.0%)
Sep 1990
-
-$164.60M(-34.1%)
-$600.20M(+37.8%)
Jun 1990
-
-$249.80M(+34.4%)
-$435.60M(+134.4%)
Mar 1990
-
-$185.80M
-$185.80M
Dec 1989
-$1.02B(+96.1%)
-
-
Dec 1988
-$521.20M(+29.8%)
-
-
Dec 1987
-$401.61M(+13.3%)
-
-
Dec 1986
-$354.54M(+31.1%)
-
-
Dec 1985
-$270.34M(-15.6%)
-
-
Dec 1984
-$320.28M(+6.9%)
-
-
Dec 1983
-$299.75M(+31.1%)
-
-
Dec 1982
-$228.62M(+15.7%)
-
-
Dec 1981
-$197.52M(+2.8%)
-
-
Dec 1980
-$192.12M
-
-

FAQ

  • What is Abbott Laboratories annual cash flow from investing activities?
  • What is the all time high annual CFI for Abbott Laboratories?
  • What is Abbott Laboratories annual CFI year-on-year change?
  • What is Abbott Laboratories quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Abbott Laboratories?
  • What is Abbott Laboratories quarterly CFI year-on-year change?
  • What is Abbott Laboratories TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Abbott Laboratories?
  • What is Abbott Laboratories TTM CFI year-on-year change?

What is Abbott Laboratories annual cash flow from investing activities?

The current annual CFI of ABT is -$2.34B

What is the all time high annual CFI for Abbott Laboratories?

Abbott Laboratories all-time high annual cash flow from investing activities is $406.00M

What is Abbott Laboratories annual CFI year-on-year change?

Over the past year, ABT annual cash flow from investing activities has changed by +$795.00M (+25.38%)

What is Abbott Laboratories quarterly cash flow from investing activities?

The current quarterly CFI of ABT is -$582.00M

What is the all time high quarterly CFI for Abbott Laboratories?

Abbott Laboratories all-time high quarterly cash flow from investing activities is $1.57B

What is Abbott Laboratories quarterly CFI year-on-year change?

Over the past year, ABT quarterly cash flow from investing activities has changed by -$129.00M (-28.48%)

What is Abbott Laboratories TTM cash flow from investing activities?

The current TTM CFI of ABT is -$2.51B

What is the all time high TTM CFI for Abbott Laboratories?

Abbott Laboratories all-time high TTM cash flow from investing activities is $837.00M

What is Abbott Laboratories TTM CFI year-on-year change?

Over the past year, ABT TTM cash flow from investing activities has changed by -$176.00M (-7.53%)
On this page